Loading chat...
MO HB762
Bill
Status
3/3/2011
Primary Sponsor
Michael Corcoran
Click for details
AI Summary
-
Health benefit plans covering cancer chemotherapy cannot require higher co-payments, deductibles, or coinsurance for oral anticancer medications than for intravenously administered or injected chemotherapy medications.
-
Health carriers cannot comply with this requirement by increasing out-of-pocket costs for intravenous or injected cancer medications.
-
Health carriers may still require prior authorization and other appropriate utilization controls for chemotherapy coverage.
-
Supplemental insurance policies, Medicare supplements, long-term care policies, and short-term major medical policies of six months or less are exempt from these requirements.
-
Applies to health benefit plans and health carriers as defined in Missouri statute section 376.1350.
Legislative Description
Requires a health benefit plan to establish equal out-of-pocket requirements for an orally administered anti-cancer medication and an intravenously administered or injected cancer medication
Last Action
Referred: Health Insurance (H)
3/16/2011